Turnover rates of the components of systems for RNA synthesis of rat-liver nucleus, nucleolus, and nucleoplasm were investigated. Cycloheximide administered in vivo selectively diminished nucleolar RNA synthesis in vitro. In contrast to the relatively stable nucleoplasmic RNA polymerase, nucleolar RNA polymerase (polymerase I) from rat liver decay's rapidly upon cycloheximide administration, following pseudo-first order kinetics with a half-life of about 1.3 hr. Cycloheximide elicits this effect not through direct interaction with nucleolar RNA polymerase itself, nor by alteration of template function, but rather by inhibition of de novo synthesis of one or more of the protein components of nucleolar RNA polymerase. Similarly, when actinomycin-D was administered in vivo to inhibit RNA synthesis, the rate of decay of nucleolar RNA polymerase, assayed in the presence of exogenous poly d(A-T) template, was similar to that observed after cycloheximide administration. Thus, the messenger RNA(s) that codes for one or more of the catalytically essential polypeptide components of this enzyme turn over very rapidly with a half-life considerably shorter than 1.3 hr. The rapidity of turnover of both the enzyme protein and its messenger RNA(s) renders nucleolar RNA polymerase highly responsive to altered transcriptional, translational, or post-translational modulation. The marked differences in turnover rates of nucleolar and nucleoplasmic RNA polymerases indicate that at least certain of the protomeric components of nucleolar RNA polymerase I are distinct from those of nucleoplasmic RNA polymerases II and III.
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The biochemical mechanisms underlying regulation of gene transcription during hormone action and development, and in response to environmental or physiological stimuli, have been actively investigated in our own and many other laboratories. In addition to messenger RNA (mRNA), which codes for the primary structure of proteins, transfer RNA, and ribosomal RNA are also products of gene transcription. Regulation of the transcriptional synthesis of ribosomal RNA is particularly amenable to study, as it constitutes 80% of hepatic RNA and is synthesized in vitro by a reasonably well understood biosynthetic pathway in conveniently isolated nucleoli whereupon it matures, becoming cytoplasmic 18S and 28S ribosomal RNA (1) (2) (3) (4) .
Recently, we demonstrated that within a few hours after administration of cortisone in vivo there is a dramatic increase in ribosomal RNA synthesis, as measured either in vivo (5-7) or in vitro in isolated nucleoli (3) . Furthermore, this increase was due, not to increased availability of the DNA template coding for ribosomal RNA, but rather to an augmentation in the activity of the nucleolar RNA polymerase 2833 per se (3). These findings suggested that nucleolar RNA polymerase (polymerase I) may rapidly turn over and may be hormonally inducible. Several previously unexplained phenomena seemed compatible with this inference: (i) whereas the mean half-life (ti/) of the activity of nuclear RNA polymerase from whole normal liver is about 12 hr, after partial hepatectomy the increased RNA polymerase activity (presumably largely nucleolar) decays with a maximum tl1, of 2.5-3 hr (8); (ii) inhibition of protein synthesis, either with puromycin or by amino-acid deprivation, results in selective decreases in ribosomal RNA synthesis (9-13); (iii) in vivo administration of a-amanitin, a specific inhibitor of RNA polymerase II (14) (15) (16) , results in a rapid decrease in ribosomal RNA synthesis (17) , suggesting participation of rapidly turning over mRNA and protein in maintaining polymerase I levels.
To indirectly measure the turnover rate of hepatic RNA polymerase I, we used cycloheximide (Acti-Dione), a potent inhibitor of protein synthesis in animals (18, 19) . Treatment with this antibiotic selectively diminishes rates of ribosomal RNA synthesis in vivo in several eukaryotic cells, including Neurospora crassa (20) , yeast (21, 22) , chlorella (23) , Xenopus laevis (24) , HeLa cells (25) , and rat liver (2, 26 Nuclear Corp., 34.1 Ci/mol) was given intraperitoneally 20 min before they were killed to male Sprague-Dawley rats (150-200 g body weight) that were starved'overnight before use. Cycloheximide (3 mg/100 g body weight) was given intraperitoneally for 20 min or 4 hr before the animals were killed. * Acid-soluble fraction was isolated as described (40) .
t The proteins were isolated and their radioactivities were determined as described (41 Mann Research Lab.) (3 mg/100 g of body weight) and actinomycin D (Nutritional Biochemicals Corp.) (200 Ag/100 g of body weight) were injected intraperitoneally at the indicated times before the rats were killed. r-[1-14Cjleucine (New England Nuclear Corp., 34.1 Ci/mol) (5 XCi/100 g of body weight) was also administered intraperitoneally 20 min before the rats were killed.
The procedures for isolation of rat-liver nuclei, nucleoli, and nucleoplasm have been described (3) . RNA polymerase activity was assayed in vitro, with a low ionic strength-Mg+2-rich reaction mixture (29) of 0.6-0.9 ml total volume containing: 100 mM Trist HCl pH 8.2, 5 mM MgCl2, and 0.2 mM each of ATP, CTP, UTP, and GTP; 0. (2, (20) (21) (22) (23) (24) (25) (26) . Table 2 also presents U/G incorporation ratios, which, in conformance with our earlier observations (3, 29) , indicate that the nucleolar and nucleoplasmic fractions synthesize RNA in vitro the base compositions of which resemble those of ribosomal and messenger RNAs, respectively; these findings agree with the current concept that nucleoli are the sites of synthesis of guanine-rich ribosomal RNA (37) (38) (39) and the nucleoplasm is the site of synthesis of uracil-rich mRNA (1). Fig. 1 A priori cycloheximide may reduce activity of nucleolar RNA polymerase either by interacting directly with the enzyme, rendering it inactive, or by inhibiting the synthesis of one or more catalytically essential protein component(s) of the enzyme, thereby decreasing the amount of active enzyme. The following experiments tested and excluded the first of these possibilities.
(A-T) (see [8H]UTP incorporation column); poly d(A-T) codes for poly(U, A) and is not inhibited by actinomycin-D (3). It is evident from
Cycloheximide, in various concentrations, was added directly to the reaction medium during transcription of the endogenous template by the native enzyme. Fig. 2 indicates Values are given as pmol of nucleoside monophosphate incorporated/mg DNA. In addition to other components (29) , the incubation medium contained 20 mM 2-mercaptoethanol. The following were added to the incubation mixture at zero time: that even at very high concentrations this antibiotic fails to inhibit polymerase activity. However, these findings do not rule out the possibility that cycloheximide might interfere with the enzyme function only when the polymerase is unbound and requires the initiation step of RNA synthesis, in a manner similar to rifamycin inhibition of bacterial RNA polymerase (27) . Therefore, the effect in vivo of cycloheximide on nucleolar RNA polymerase was evaluated with exogenous template under conditions under which the endogenous template was not being transcribed [i.e., in the presence of actinomycin-D (3)]. The results of this study (Table 4) again indicate no direct inhibition of RNA polymerase activity by cycloheximide in vitro. We, therefore, concluded that the diminution of activity of nucleolar RNA polymerase by cycloheximide in vivo is a consequence of inhibited in vivo synthesis of one or more essential protein components of the enzyme that are metabolically unstable and turn over rapidly with a half-life of about 1.3 hr.
The half-life of the mRNA that codes for nucleolar RNA polymerase was estimated by administration of actinomycin-D in vivo to block RNA synthesis; RNA polymerase activity per se was measured in vitro with exogenous template poly d(A-T) as a function of time after administration of actinomycin-D in vivo. Fig. 3 depicts a decay curve for RNA polymerase obtained under these conditions, that is similar to that obtained in cycloheximide-treated animals (Fig. 1) . The absence of extended translational synthesis of polymerase after administration of acfinomycin D indicates that the mRNA(s) that codes for the rapidly turning over protein component(s) of nucleolar RNA polymerase is itself turning over very rapidly with a half-life much shorter than 1.3 hr.
The present study provides the following evidence that one or more polypeptide components of nucleolar RNA polymerase, as well as the mRNA (s) that code for this component(s), /are indeed among the most rapidly turning over macromolecules in liver. Isolated nucleoli are capable of template-dependent nucleotide incorporation in vitro with a U/G base ratio that corresponds to ribosomal precursor RNA. Cycloheximide has no direct effect in vitro on preformed RNA polymerase, whereas inhibition of protein synthesis mediated by cycloheximide in vivo results in a fall in nucleolar RNA polymerase activity, which is pseudo-first 
